Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4115)
All Articles published online
|
Sep 28, 2010 (publication date) through Feb 24, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sun JC, Liang XT, Pan K, Wang H, Zhao JJ, Li JJ, Ma HQ, Chen YB, Xia JC. High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients. World J Gastroenterol 2010; 16(36): 4611-4615 [PMID: 20857535 DOI: 10.3748/wjg.v16.i36.4611] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i36/4611.htm |
| Number | Citing Articles |
| 1 |
Meng Li, Di Zhong, Guozhong Li. Regulatory role of local tissue signal Del-1 in cancer and inflammation: a review. Cellular & Molecular Biology Letters 2021; 26(1) doi: 10.1186/s11658-021-00274-9
|
| 2 |
Soo Jung Lee, Jeeyeon Lee, Jin Hyang Jung, Ho Yong Park, Pyong-Gon Moon, Yee Soo Chae, Moon-Chang Baek. Exosomal Del-1 as a Potent Diagnostic Marker for Breast Cancer: Prospective Cohort Study. Clinical Breast Cancer 2021; 21(6): e748 doi: 10.1016/j.clbc.2021.02.002
|
| 3 |
Saba Tabasum, Dinesh Thapa, Anita Giobbie-Hurder, Jason L. Weirather, Marco Campisi, Pieter J. Schol, Xiaoyu Li, Jingjing Li, Charles H. Yoon, Michael P. Manos, David A. Barbie, F. Stephen Hodi. EDIL3 as an Angiogenic Target of Immune Exclusion Following Checkpoint Blockade. Cancer Immunology Research 2023; 11(11): 1493 doi: 10.1158/2326-6066.CIR-23-0171
|
| 4 |
Lauren Patterson Cobb, Sharareh Siamakpour-Reihani, Dadong Zhang, Xiaodi Qin, Kouros Owzar, Chunxiao Zhou, Thomas P. Conrads, G. Larry Maxwell, Kathleen M. Darcy, Nicholas W. Bateman, Tracy Litzi, Victoria Bae-Jump, Angeles Alvarez Secord. Obesity and altered angiogenic-related gene expression in endometrial cancer. Gynecologic Oncology 2021; 163(2): 320 doi: 10.1016/j.ygyno.2021.08.010
|
| 5 |
Rahsan Ilikci-Sagkan, Dilara Fatma Akin, Recep Liman, Muhammad Muddassir Ali. In silico analysis of DEL-1 and inflammation-related genes in lung squamous cell carcinoma. Immunobiology 2024; 229(5): 152838 doi: 10.1016/j.imbio.2024.152838
|
| 6 |
Shu-Heng Jiang, Yang Wang, Jian-Yu Yang, Jun Li, Ming-Xuan Feng, Ya-Hui Wang, Xiao-Mei Yang, Ping He, Guang-Ang Tian, Xiao-Xin Zhang, Qing Li, Xiao-Yan Cao, Yan-Miao Huo, Min-Wei Yang, Xue-Liang Fu, Jiao Li, De-Jun Liu, Miao Dai, Shan-Yun Wen, Jian-Ren Gu, Jie Hong, Rong Hua, Zhi-Gang Zhang, Yong-Wei Sun. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer. Oncotarget 2016; 7(4): 4226 doi: 10.18632/oncotarget.6772
|
| 7 |
Seyed Hamed Jafari, Zahra Saadatpour, Arash Salmaninejad, Fatemeh Momeni, Mojgan Mokhtari, Javid Sadri Nahand, Majid Rahmati, Hamed Mirzaei, Mojtaba Kianmehr. Breast cancer diagnosis: Imaging techniques and biochemical markers. Journal of Cellular Physiology 2018; 233(7): 5200 doi: 10.1002/jcp.26379
|
| 8 |
Hongping Xia, Jianxiang Chen, Ming Shi, Hengjun Gao, Karthik Sekar, Veerabrahma Pratap Seshachalam, London Lucien P.J. Ooi, Kam M. Hui. EDIL3 is a novel regulator of epithelial-mesenchymal transition controlling early recurrence of hepatocellular carcinoma. Journal of Hepatology 2015; 63(4): 863 doi: 10.1016/j.jhep.2015.05.005
|
| 9 |
Lianyue Guan, Qiang Luo, Na Liang, Hongyu Liu. A prognostic prediction system for hepatocellular carcinoma based on gene co‑expression network. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7494
|
| 10 |
Mukesh Verma, Tram Kim Lam, Elizabeth Hebert, Rao L Divi. Extracellular vesicles: potential applications in cancer diagnosis, prognosis, and epidemiology. BMC Clinical Pathology 2015; 15(1) doi: 10.1186/s12907-015-0005-5
|
| 11 |
Zixiang Lin, Ce Jiang, Di Lv, Degui Lin. Identification of EDIL3 biomarkers as a biomarker and potential therapeutic target of canine mammary carcinomas based on integrated bioinformatics analysis. Veterinary Immunology and Immunopathology 2022; 249: 110432 doi: 10.1016/j.vetimm.2022.110432
|
| 12 |
Helene Damhofer, Jan Paul Medema, Veronique L. Veenstra, Liviu Badea, Irinel Popescu, Henk Roelink, Maarten F. Bijlsma. Assessment of the stromal contribution to Sonic Hedgehog‐dependent pancreatic adenocarcinoma. Molecular Oncology 2013; 7(6): 1031 doi: 10.1016/j.molonc.2013.08.004
|
| 13 |
Jae-Wook Chung, Hyun Tae Kim, Yun-Sok Ha, Eun Hye Lee, So Young Chun, Chan-Hyeong Lee, Kyeong Hyeon Byeon, Seock Hwan Choi, Jun Nyung Lee, Bum Soo Kim, Tae-Hwan Kim, Eun Sang Yoo, Ghil Suk Yoon, Moon-Chang Baek, Tae Gyun Kwon, Jeremy Yuen Chun Teoh. Identification of a novel non-invasive biological marker to overcome the shortcomings of PSA in diagnosis and risk stratification for prostate cancer: Initial prospective study of developmental endothelial locus-1 protein. PLOS ONE 2021; 16(4): e0250254 doi: 10.1371/journal.pone.0250254
|
| 14 |
Bin Ke, Peng Jin, Xue-Jun Wang, Ning Liu, Han Liang, Ru-Peng Zhang. Oncogenic and immunological role of EDIL3 in human tumours: From pan-cancer analysis to validation in gastric cancer. Heliyon 2024; 10(11): e32291 doi: 10.1016/j.heliyon.2024.e32291
|
| 15 |
Ming-Xuan Feng, Ming-Ze Ma, Ying Fu, Jun Li, Tao Wang, Feng Xue, Jian-Jun Zhang, Wen-Xin Qin, Jian-Ren Gu, Zhi-Gang Zhang, Qiang Xia. Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation. Molecular Cancer 2014; 13(1) doi: 10.1186/1476-4598-13-226
|
| 16 |
Melika Marani, Vrinda Madan, Thomas K. Le, Junwen Deng, Kevin K. Lee, Emily Z. Ma, Shawn G. Kwatra. Dysregulation of the Skin–Liver Axis in Prurigo Nodularis: An Integrated Genomic, Transcriptomic, and Population-Based Analysis. Genes 2024; 15(2): 146 doi: 10.3390/genes15020146
|
| 17 |
Wei Shen, Shanbang Zhu, Haifeng Qin, Ming Zhong, Jinhui Wu, Rui Zhang, Hongyuan Song. EDIL3 knockdown inhibits retinal angiogenesis through the induction of cell cycle arrest in vitro. Molecular Medicine Reports 2017; 16(4): 4054 doi: 10.3892/mmr.2017.7122
|
| 18 |
Hong Li, Yi Wang, Lei Zhang, Haojie Lu, Zhongjun Zhou, Liming Wei, Pengyuan Yang. Facile synthesis of novel magnetic silica nanoparticles functionalized with layer-by-layer detonation nanodiamonds for secretome study. The Analyst 2015; 140(23): 7886 doi: 10.1039/C5AN01432H
|
| 19 |
Seung-Hwan Lee, Dong-Young Kim, Feifeng Jing, Hyesoon Kim, Chae-Ok Yun, Deok-Jong Han, Eun Young Choi. Del-1 overexpression potentiates lung cancer cell proliferation and invasion. Biochemical and Biophysical Research Communications 2015; 468(1-2): 92 doi: 10.1016/j.bbrc.2015.10.159
|
| 20 |
Ariane Aigelsreiter, Johannes Haybaeck, Silvia Schauer, Tobias Kiesslich, Kira Bettermann, Antonia Griessbacher, Tatjana Stojakovic, Thomas Bauernhofer, Hellmut Samonigg, Peter Kornprat, Carolin Lackner, Martin Pichler. NEMO expression in human hepatocellular carcinoma and its association with clinical outcome. Human Pathology 2012; 43(7): 1012 doi: 10.1016/j.humpath.2011.08.009
|
| 21 |
Bin Ke, Zheng-Kai Liang, Bin Li, Xue-Jun Wang, Ning Liu, Han Liang, Ru-Peng Zhang. EDIL3 is a potential prognostic biomarker that correlates with immune infiltrates in gastric cancer. PeerJ 2023; 11: e15559 doi: 10.7717/peerj.15559
|
| 22 |
Ludwig Wilkens, Rolf Jaggi, Caroline Hammer, Daniel Inderbitzin, Olivier Giger, Nils von Neuhoff. The homeobox gene HLXB9 is upregulated in a morphological subset of poorly differentiated hepatocellular carcinoma. Virchows Archiv 2011; 458(6): 697 doi: 10.1007/s00428-011-1070-5
|
| 23 |
Rui Chen, George I. Mias, Jennifer Li-Pook-Than, Lihua Jiang, Hugo Y.K. Lam, Rong Chen, Elana Miriami, Konrad J. Karczewski, Manoj Hariharan, Frederick E. Dewey, Yong Cheng, Michael J. Clark, Hogune Im, Lukas Habegger, Suganthi Balasubramanian, Maeve O'Huallachain, Joel T. Dudley, Sara Hillenmeyer, Rajini Haraksingh, Donald Sharon, Ghia Euskirchen, Phil Lacroute, Keith Bettinger, Alan P. Boyle, Maya Kasowski, Fabian Grubert, Scott Seki, Marco Garcia, Michelle Whirl-Carrillo, Mercedes Gallardo, Maria A. Blasco, Peter L. Greenberg, Phyllis Snyder, Teri E. Klein, Russ B. Altman, Atul J. Butte, Euan A. Ashley, Mark Gerstein, Kari C. Nadeau, Hua Tang, Michael Snyder. Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes. Cell 2012; 148(6): 1293 doi: 10.1016/j.cell.2012.02.009
|
| 24 |
Carla J. Beckham, Jayme Olsen, Peng-Nien Yin, Chia-Hao Wu, Huei-Ju Ting, Fred K. Hagen, Emelian Scosyrev, Edward M. Messing, Yi-Fen Lee. Bladder Cancer Exosomes Contain EDIL-3/Del1 and Facilitate Cancer Progression. Journal of Urology 2014; 192(2): 583 doi: 10.1016/j.juro.2014.02.035
|
| 25 |
Marcin Oplawski, Konrad Dziobek, Nikola Zmarzły, Beniamin Grabarek, Barbara Tomala, Ewa Leśniak, Iwona Adwent, Piotr Januszyk, Dariusz Dąbruś, Dariusz Boroń. Evaluation of Changes in the Expression Pattern of EDIL3 in Different Grades of Endometrial Cancer. Current Pharmaceutical Biotechnology 2019; 20(6): 483 doi: 10.2174/1389201020666190408112822
|
| 26 |
Soo Jung Lee, Jae-Hwan Jeong, Seung Hee Kang, Jieun Kang, Eun Ae Kim, Jeeyeon Lee, Jin Hyang Jung, Ho Yong Park, Yee Soo Chae. MicroRNA-137 Inhibits Cancer Progression by Targeting Del-1 in Triple-Negative Breast Cancer Cells. International Journal of Molecular Sciences 2019; 20(24): 6162 doi: 10.3390/ijms20246162
|
| 27 |
Miroslava Stastna, Jennifer E. Van Eyk. Secreted proteins as a fundamental source for biomarker discovery. PROTEOMICS 2012; 12(4-5): 722 doi: 10.1002/pmic.201100346
|
| 28 |
Taylor Pini, Tamara Leahy, Clement Soleilhavoup, Guillaume Tsikis, Valerie Labas, Lucie Combes-Soia, Gregoire Harichaux, Jessica P. Rickard, Xavier Druart, Simon P. de Graaf. Proteomic Investigation of Ram Spermatozoa and the Proteins Conferred by Seminal Plasma. Journal of Proteome Research 2016; 15(10): 3700 doi: 10.1021/acs.jproteome.6b00530
|
| 29 |
Yeon Hee Ryu, Yoon Jae Lee, Ki-Joo Kim, Su Jin Lee, Yu-Na Han, Jong-Won Rhie. Epidermal Growth Factor (EGF)-Like Repeats and Discoidin I-Like Domains 3 (EDIL3): A Potential New Therapeutic Tool for the Treatment of Keloid Scars. Tissue Engineering and Regenerative Medicine 2017; 14(3): 267 doi: 10.1007/s13770-017-0034-5
|
| 30 |
Nitu Bansal, Prasun J. Mishra, Mark Stein, Robert S. DiPaola, Joseph R. Bertino. Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells. Oncotarget 2015; 6(17): 15321 doi: 10.18632/oncotarget.4148
|
| 31 |
Pyong-Gon Moon, Jeong-Eun Lee, Young-Eun Cho, Soo Jung Lee, Jin Hyang Jung, Yee Soo Chae, Han-Ik Bae, Young-Bum Kim, In-San Kim, Ho Yong Park, Moon-Chang Baek. Identification of Developmental Endothelial Locus-1 on Circulating Extracellular Vesicles as a Novel Biomarker for Early Breast Cancer Detection. Clinical Cancer Research 2016; 22(7): 1757 doi: 10.1158/1078-0432.CCR-15-0654
|